|
注册号: Registration number: |
ChiCTR2600122528 |
|
最近更新日期: Date of Last Refreshed on: |
2026-04-14 17:44:04 |
|
注册时间: Date of Registration: |
2026-04-14 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
35家中国三甲医院癫痫患者无发作率及治疗现状的基线研究 |
|
Public title: |
A Baseline Study on Seizure-Free Rates and the Current State of Treatment Among Epilepsy Patients in 35 Grade A Tertiary Hospitals in China |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
35家中国三甲医院癫痫患者无发作率及治疗现状的基线研究 |
|
Scientific title: |
A Baseline Study on Seizure-Free Rates and the Current State of Treatment Among Epilepsy Patients in 35 Grade A Tertiary Hospitals in China |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王玉平 |
研究负责人: |
王玉平 |
|
Applicant: |
Wang Yuping |
Study leader: |
Yuing Wang |
|
申请注册联系人电话: Applicant telephone: |
+86 311 87157792 |
研究负责人电话:
Study leader's |
+86 13501186298 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
wangyuping01@sina.cn |
研究负责人电子邮件: Study leader's E-mail: |
wangyuping01@sina.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
河北省石家庄市东岗路89号 |
研究负责人通讯地址: |
河北省石家庄市东岗路89号 |
|
Applicant address: |
No. 89, Donggang Road, Shijiazhuang, Hebei |
Study leader's address: |
No. 89, Donggang Road, Shijiazhuang, Hebei |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
河北医科大学第一医院 |
||
|
Applicant's institution: |
the first hospital of hebei medical university |
||
|
研究负责人所在单位: |
河北医科大学第一医院 |
||
|
Affiliation of the Leader: |
the first hospital of hebei medical university |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
【2026】研审第(Y020)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
河北医科大学第一医院临床研究伦理审查委员会 |
||
|
Name of the ethic committee: |
Clinical Research Ethics Committee of the First Hospital of Hebei Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-03-27 00:00:00 | ||
|
伦理委员会联系人: |
杨谦谦 |
||
|
Contact Name of the ethic committee: |
Yang QianQian |
||
|
伦理委员会联系地址: |
河北省石家庄市东岗路89号 |
||
|
Contact Address of the ethic committee: |
No. 89, Donggang Road, Shijiazhuang, Hebei |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 311 87156679 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
476182576@qq.com |
|
研究实施负责(组长)单位: |
河北医科大学第一医院 |
||||||||||||||||||||||
|
Primary sponsor: |
the first hospital of hebei medical university |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
河北省石家庄市东岗路89号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 89, Donggang Road, Shijiazhuang, Hebei |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自选课题(自筹) |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-selected research topic (self-funded) |
||||||||||||||||||||||
|
研究疾病: |
癫痫 |
||||||||||||||||||||||
|
Target disease: |
Epilepsy |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
1.系统描述中国三甲医院就诊癫痫患者的癫痫发作类型分布特征,明确不同发作类型的构成比例。 2.调查患者的无发作情况,分析无发作率及影响无发作的相关因素。 3.梳理就诊患者的临床特征,包括发病年龄、病程长短、伴随疾病等关键信息。 4.总结ASMs的使用现状,涵盖药物种类选择、单一用药与联合用药比例、用药剂量及疗程等内容。 |
||||||||||||||||||||||
|
Objectives of Study: |
1.To systematically describe the distribution of seizure types among epilepsy patients attending tertiary hospitals in China, and to determine the proportion of different seizure types. 2.To investigate seizure-free periods among patients, and to analyse seizure-free rates and the factors influencing them. 3.To summarise the clinical characteristics of the patients, including key information such as age at onset, duration of illness, and comorbidities. 4.Summarise the current status of antiepileptic drug (AED) use, covering aspects such as the selection of drug types, the proportions of monotherapy versus combination therapy, dosages, and treatment duration.Translated with DeepL.com (free version) |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1. 患者目前或以前仅诊断为假性癫痫发作或其他与癫痫发作产生混淆的非癫痫发作事件; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. The patient has been diagnosed, either currently or in the past, solely with pseudoseizures or other non-epileptic events that may be confused with epileptic seizures; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-04-01 00:00:00至 To 2026-10-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-04-15 00:00:00 至 To 2026-10-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Do not share |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
35家中国三甲医院癫痫患者无发作率及治疗现状的基线研究CRF表格 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Baseline Study on Seizure-Free Rates and Current Treatment Practices Among Epilepsy Patients in 35 Grade A Tertiary Hospitals in China: CRF Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |